Top U.S. market share of SNRIs based on precriptions 2013
This statistic displays the market share of the top nine serotonin-norepinephrine reuptake inhibitors (SNRIs) based on total U.S. prescriptions, in 2013. In that year, Pristiq was among the leading SNRIs with a market share of 7.9 percent based on SNRI prescriptions in the United States. SNRIs are a type of antidepressant drug used to treat major depression disorder or other mood disorders. They can also be used for anxiety disorders, obsessive-compulsive disorder, and other related disorders.
